Ransom Advisory’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$386K Sell
1,100
-100
-8% -$33.8K 0.15% 95
2025
Q3
$388K Hold
1,200
0.17% 81
2025
Q2
$467K Hold
1,200
0.22% 76
2025
Q1
$522K Hold
1,200
0.26% 74
2024
Q4
$443K Sell
1,200
-125
-9% -$52.3K 0.2% 87
2024
Q3
$689K Hold
1,325
0.32% 63
2024
Q2
$718K Hold
1,325
0.36% 59
2024
Q1
$687K Buy
+1,325
New +$659K 0.37% 61

Other funds holding ELV

Ransom Advisory's ELV Position: Q4 2025 in Review

Ransom Advisory reduced its Elevance Health (ELV) stake by 8.3% in Q4 2025, selling an estimated $33.8K and leaving 1,100 shares worth $386K. The position accounts for 0.15% of the portfolio, ranked #95.

Ransom Advisory first reported a position in ELV in Q1 2024 and has held it in 8 quarters since. The position peaked at $718K in Q2 2024. 1,554 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Ransom Advisory held 1,100 shares of Elevance Health worth $386K as of Q4 2025.
  • Ransom Advisory sold 100 Elevance Health shares in Q4 2025, an estimated $33.8K.
  • Elevance Health made up 0.15% of Ransom Advisory's portfolio in Q4 2025, its #95 holding.
  • Ransom Advisory first reported a position in Elevance Health in Q1 2024 and has held it in 8 quarters since.
  • Ransom Advisory's Elevance Health position peaked at $718K in Q2 2024.
  • 1,554 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.